Intelligence Profile
Science
Mechanism of Action
Platelet-rich plasma (PRP) tendon and ligament injection therapy works by delivering concentrated platelets and their associated growth factors directly to injured or degenerative tissue sites. However, the precise molecular mechanisms remain incompletely understood based on current evidence.
Platelet Activation and Growth Factor Release
When PRP is injected into tendon or ligament tissue, platelets become activated and degranulate, releasing stored growth factors and bioactive proteins. These include platelet-derived growth factor (PDGF), transforming growth factor-beta (TGF-β), vascular endothelial growth factor (VEGF), and insulin-like growth factor (IGF-1), among others. This concentrated delivery of growth factors is hypothesized to stimulate the body's natural healing cascade.
Proposed Tissue Repair Mechanisms
The released growth factors are theorized to promote several healing processes:
- Enhanced cellular proliferation and migration of tenocytes and fibroblasts
- Stimulation of collagen synthesis and extracellular matrix remodeling
- Promotion of angiogenesis (new blood vessel formation) in poorly vascularized tendon tissue
- Modulation of inflammatory responses
Evidence Limitations
While bibliometric studies show substantial research interest in PRP for tendon and ligament injuries over the past two decades, the available evidence primarily consists of clinical outcome studies and veterinary research rather than detailed mechanistic investigations. The molecular pathways by which PRP exerts its effects in human tendon and ligament healing require further elucidation through controlled laboratory studies.
Additionally, PRP preparation protocols vary significantly between studies and clinical applications, potentially affecting the concentration and activity of bioactive factors, making it difficult to establish consistent mechanisms of action.
This information is for educational purposes only and should not replace professional medical consultation.